Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Esmolol hydrochloride
AOP Orphan Ltd
C07AB09
Esmolol hydrochloride
2.5gram
Powder for solution for infusion
Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: ; GTIN: 9120015450452
1 PACKAGE LEAFLET: INFORMATION FOR THE USER ESMOLOL HYDROCHLORIDE 2500 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION Esmolol hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or nurse. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What ESMOLOL HYDROCHLORIDE is and what it is used for 2. What you need to know before you use ESMOLOL HYDROCHLORIDE 3. How to use ESMOLOL HYDROCHLORIDE 4. Possible side effects 5. How to store ESMOLOL HYDROCHLORIDE 6. Contents of the pack and further information 1. WHAT ESMOLOL HYDROCHLORIDE IS AND WHAT IT IS USED FOR Esmolol belongs to the group of beta blockers these medicines slow down the heart beat and reduce blood pressure. Esmolol is used for short term treatment if your heart beats too fast. Esmolol is also used during or straight after surgery if your blood pressure gets too high and/or your heart beats too fast. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE ESMOLOL HYDROCHLORIDE DO NOT USE ESMOLOL HYDROCHLORIDE IF YOU - are allergic to esmolol hydrochloride or any of the other ingredients of this medicine (listed in section 6) - have a very slow heart beat - have a problem with the electrical messages that control your heartbeat (a problem called “heart block”). - have a serious heart failure - have a fast or alternating fast and slow heartbeat (a problem called the “Sick Sinus” syndrome) - have a phaeochromocytoma not yet treated. (A phaeochromocytoma is a condition of the adrenal gland that may be accompanied by a sudden increase of blood pressure, severe headache, sweating and increased heartbeat) - have a problem with Read the complete document
OBJECT 1 ESMOLOL HYDROCHLORIDE 2500 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION Summary of Product Characteristics Updated 12-Feb-2018 | AOP Orphan Pharmaceuticals AG 1. Name of the medicinal product ESMOLOL HYDROCHLORIDE 2500 mg powder for concentrate for solution for infusion 2. Qualitative and quantitative composition A vial of 50 ml contains 2500 mg esmolol hydrochloride. Each ml of reconstituted concentrate for solution for infusion contains 50 mg esmolol hydrochloride (50 mg/ml). Each ml of the diluted solution for infusion contains 10 mg esmolol hydrochloride (10 mg/ml). For the full list of excipients, see section 6.1. 3. Pharmaceutical form Powder for concentrate for solution for infusion The powder is white to almost white. 4. Clinical particulars 4.1 Therapeutic indications Esmolol hydrochloride is indicated for supraventricular tachycardia (except for pre- excitation syndromes), and for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short acting agent is desirable. Esmolol hydrochloride is also indicated for tachycardia and hypertension occurring in the perioperative phase and non-compensatory sinus tachycardia where, in the physician's judgement the rapid heart rate requires specific intervention. Esmolol hydrochloride is not intended for use in chronic settings. 4.2 Posology and method of administration ESMOLOL HYDROCHLORIDE 2500 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION MUST NOT BE ADMINISTERED WITHOUT RECONSTITUTION/DILUTION. The reconstituted/diluted solution for infusion must be used immediately after opening (see sections 4.4 and 6). The administration of incorrect reconstituted/diluted ESMOLOL HYDROCHLORIDE may result in death (see section 4.4). POSOLOGY SUPRAVENTRICULAR TACHYARRHYTHMIA The dosage of esmolol should be titrated individually. A starting dose is required, followed by a maintenance dosage. The effective dose Read the complete document